Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Tizanidine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tizanidine 2mg tablets
1002020T0AAABAB
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 19,278 |
|
Tizanidine 4mg tablets
1002020T0AAAAAA
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 10,531 |
|
Tizanidine 2mg/5ml oral solution
1002020T0AAAIAI
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 125 |
|
Tizanidine 2mg/5ml oral suspension
1002020T0AAAJAJ
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 91 |
|
Tizanidine 4mg/5ml oral liquid
1002020T0AAAEAE
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 5mg/5ml oral suspension
1002020T0AAAKAK
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 6mg/5ml oral suspension
1002020T0AAALAL
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 8mg/5ml oral liquid
1002020T0AAAHAH
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.